HRP20050779A2 - Supstituted benzoylureidopyridyl-piperidine and pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof - Google Patents
Supstituted benzoylureidopyridyl-piperidine and pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereofInfo
- Publication number
- HRP20050779A2 HRP20050779A2 HR20050779A HRP20050779A HRP20050779A2 HR P20050779 A2 HRP20050779 A2 HR P20050779A2 HR 20050779 A HR20050779 A HR 20050779A HR P20050779 A HRP20050779 A HR P20050779A HR P20050779 A2 HRP20050779 A2 HR P20050779A2
- Authority
- HR
- Croatia
- Prior art keywords
- piperidine
- production
- carboxylic acid
- acid derivatives
- supstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10309929A DE10309929B4 (de) | 2003-03-07 | 2003-03-07 | Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
| PCT/EP2004/001735 WO2004078743A1 (de) | 2003-03-07 | 2004-02-21 | Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, verfahren zu deren herstellung und deren verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20050779A2 true HRP20050779A2 (en) | 2006-10-31 |
Family
ID=32945839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20050779A HRP20050779A2 (en) | 2003-03-07 | 2004-02-21 | Supstituted benzoylureidopyridyl-piperidine and pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1603895B1 (enExample) |
| JP (1) | JP2006519795A (enExample) |
| KR (1) | KR20050108487A (enExample) |
| CN (1) | CN1759109A (enExample) |
| AT (1) | ATE386735T1 (enExample) |
| AU (1) | AU2004218267A1 (enExample) |
| BR (1) | BRPI0408148A (enExample) |
| CA (1) | CA2518322A1 (enExample) |
| CO (1) | CO5690587A2 (enExample) |
| DE (2) | DE10309929B4 (enExample) |
| HR (1) | HRP20050779A2 (enExample) |
| MA (1) | MA27745A1 (enExample) |
| MX (1) | MXPA05009122A (enExample) |
| NO (1) | NO20054418L (enExample) |
| PL (1) | PL377293A1 (enExample) |
| RU (1) | RU2005131011A (enExample) |
| WO (1) | WO2004078743A1 (enExample) |
| ZA (1) | ZA200506119B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006055435A1 (en) | 2004-11-15 | 2006-05-26 | Bristol-Myers Squibb Company | 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors |
| WO2006053274A2 (en) | 2004-11-15 | 2006-05-18 | Bristol-Myers Squibb Company | 2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| US7226942B2 (en) | 2004-11-15 | 2007-06-05 | Bristol-Myers Squibb Company | 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| US7365061B2 (en) | 2004-11-15 | 2008-04-29 | Bristol-Myers Squibb Company | 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
| MX2012003389A (es) * | 2009-10-06 | 2012-04-10 | Bristol Myers Squibb Co | Moduladores de gpr40 de pirrolidina. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3034004A1 (de) * | 1980-09-10 | 1982-04-22 | Hoechst Ag, 6000 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
| DE10116768A1 (de) * | 2001-04-04 | 2002-10-10 | Aventis Pharma Gmbh | Acylphenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| CA2411082A1 (en) * | 2000-06-09 | 2002-12-05 | Aventis Pharma Deutschland Gmbh | Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| DE10125567B4 (de) * | 2001-05-25 | 2004-08-26 | Aventis Pharma Deutschland Gmbh | Carbonamid substituierte Phenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| IL164249A0 (en) * | 2002-04-11 | 2005-12-18 | Aventis Pharma Gmbh | Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use |
| CA2493373A1 (en) * | 2002-07-11 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| AU2003249937A1 (en) * | 2002-07-12 | 2004-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
-
2003
- 2003-03-07 DE DE10309929A patent/DE10309929B4/de not_active Expired - Fee Related
-
2004
- 2004-02-21 KR KR1020057016583A patent/KR20050108487A/ko not_active Withdrawn
- 2004-02-21 CA CA002518322A patent/CA2518322A1/en not_active Abandoned
- 2004-02-21 EP EP04713467A patent/EP1603895B1/de not_active Expired - Lifetime
- 2004-02-21 BR BRPI0408148-0A patent/BRPI0408148A/pt not_active IP Right Cessation
- 2004-02-21 AT AT04713467T patent/ATE386735T1/de not_active IP Right Cessation
- 2004-02-21 WO PCT/EP2004/001735 patent/WO2004078743A1/de not_active Ceased
- 2004-02-21 HR HR20050779A patent/HRP20050779A2/xx not_active Application Discontinuation
- 2004-02-21 RU RU2005131011/04A patent/RU2005131011A/ru not_active Application Discontinuation
- 2004-02-21 DE DE502004006253T patent/DE502004006253D1/de not_active Expired - Lifetime
- 2004-02-21 AU AU2004218267A patent/AU2004218267A1/en not_active Abandoned
- 2004-02-21 CN CNA2004800062407A patent/CN1759109A/zh active Pending
- 2004-02-21 JP JP2006504448A patent/JP2006519795A/ja not_active Ceased
- 2004-02-21 MX MXPA05009122A patent/MXPA05009122A/es unknown
- 2004-02-21 PL PL377293A patent/PL377293A1/pl not_active Application Discontinuation
-
2005
- 2005-08-01 ZA ZA200506119A patent/ZA200506119B/en unknown
- 2005-09-06 CO CO05089471A patent/CO5690587A2/es not_active Application Discontinuation
- 2005-09-07 MA MA28485A patent/MA27745A1/fr unknown
- 2005-09-23 NO NO20054418A patent/NO20054418L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA27745A1 (fr) | 2006-02-01 |
| EP1603895A1 (de) | 2005-12-14 |
| DE10309929B4 (de) | 2006-02-23 |
| BRPI0408148A (pt) | 2006-03-01 |
| PL377293A1 (pl) | 2006-01-23 |
| CA2518322A1 (en) | 2004-09-16 |
| CO5690587A2 (es) | 2006-10-31 |
| JP2006519795A (ja) | 2006-08-31 |
| RU2005131011A (ru) | 2006-05-10 |
| KR20050108487A (ko) | 2005-11-16 |
| CN1759109A (zh) | 2006-04-12 |
| WO2004078743A1 (de) | 2004-09-16 |
| ZA200506119B (en) | 2006-11-29 |
| EP1603895B1 (de) | 2008-02-20 |
| MXPA05009122A (es) | 2005-10-20 |
| AU2004218267A1 (en) | 2004-09-16 |
| NO20054418L (no) | 2005-09-23 |
| ATE386735T1 (de) | 2008-03-15 |
| DE502004006253D1 (de) | 2008-04-03 |
| DE10309929A1 (de) | 2004-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20050532A2 (en) | Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof | |
| HRP20050531B1 (hr) | Novi aromatski derivati fluorglikozida, lijek koji sadrži te spojeve i njihova upotreba | |
| ATE534650T1 (de) | Neue cyanothiazolide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| TNSN05194A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
| TNSN06409A1 (en) | Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof | |
| MX2020014098A (es) | Compuestos heterocíclicos y de heteroarilo para tratar la enfermedad de huntington. | |
| MXPA02011458A (es) | Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos. | |
| CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
| GB0313612D0 (en) | Organic compounds | |
| CY1111327T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος | |
| ATE283265T1 (de) | 8,8a-dihydro-indeno (1,2-d)thiazol-derivate, die in 8a-stellung substituiert sind, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel z.b. als anorektika | |
| MX2024001417A (es) | Compuestos de heteroarilo para tratar la enfermedad de huntington. | |
| MX2024014435A (es) | Compuestos heterociclicos y heteroarilo para el tratamiento de la enfermedad de huntington | |
| HRP20050744A2 (en) | 4-(3-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivates and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis | |
| MX2025002790A (es) | Derivados de piperidina 2-sustituidos, metodos de preparacion y usos medicinales de los mismos | |
| HRP20050779A2 (en) | Supstituted benzoylureidopyridyl-piperidine and pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof | |
| DE50311923D1 (de) | Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| HRP20050715A2 (en) | Substituted 3-(benzoylureido)-thiophene derivatives, method for the production and use thereof | |
| IL176914A0 (en) | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
| HRP20050741A2 (en) | 1,3-substituted cycloalkyl containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments | |
| IL176915A0 (en) | Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments | |
| HRP20050667A2 (en) | Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof | |
| TNSN06233A1 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
| ATE305305T1 (de) | Verwendung einer kombination von nicotinsäuren oder deren derivaten und riboflavin zur herstellung eines arzneimittels zur behandlung von primären kopfschmerzen | |
| ATE397597T1 (de) | Neue thiophenacylhydrazinoderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel, pharmazeutische zusammensetzungen und neue anwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20051229 Year of fee payment: 3 |
|
| A1OB | Publication of a patent application | ||
| OBST | Application withdrawn |